{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T14:10:10Z","timestamp":1763388610550,"version":"3.45.0"},"reference-count":45,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.25122\/jml-2025-0125","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T14:04:18Z","timestamp":1763388258000},"page":"804-810","source":"Crossref","is-referenced-by-count":0,"title":["Recent investigations on the impact of levonorgestrel and 17\u03b2-ethinylestradiol on melanoma"],"prefix":"10.25122","volume":"18","author":[{"given":"Alexandra-Denisa","family":"Semenescu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Faculty of Pharmacy, Victor Babe\u0219 University of Medicine and Pharmacy, Timisoara, Romania","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Research Center for Pharmaco-Toxicological Evaluations, Faculty of Pharmacy, Victor Babe\u0219 University of Medicine and Pharmacy, Timisoara, Romania","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florina","family":"Borozan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Faculty of Medicine, Victor Babe\u0219 University of Medicine and Pharmacy, Timisoara, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larisa","family":"Tomescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Faculty of Medicine, Victor Babe\u0219 University of Medicine and Pharmacy, Timisoara, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioan","family":"Sas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Faculty of Medicine, Victor Babe\u0219 University of Medicine and Pharmacy, Timisoara, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10755","reference":[{"issue":"8","key":"ref1","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/s1470-2045(05)70273-4","article-title":"Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment","volume":"6","author":"Cogliano V, Grosse Y, Baan R, Straif K, Secretan B, El Ghissassi F, WHO International Agency for Research on Cancer","year":"2005","unstructured":"1. Cogliano V, Grosse Y, Baan R, Straif K, Secretan B, El Ghissassi F, WHO International Agency for Research on Cancer, Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment, Lancet Oncol, 2005;6(8):552-553","journal-title":"Lancet Oncol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.3332\/ecancer.2022.1416","article-title":"Review of the literature on combined oral contraceptives and cancer","volume":"16","author":"Kamani M, Akgor U, G\u00fcltekin M","year":"2022","unstructured":"2. Kamani M, Akgor U, G\u00fcltekin M, Review of the literature on combined oral contraceptives and cancer, Ecancermedicalscience, 2022;161416","journal-title":"Ecancermedicalscience"},{"issue":"2","key":"ref3","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.3109\/13625187.2010.513071","article-title":"History of oral contraception","volume":"15","author":"Dhont M","year":"2010","unstructured":"3. Dhont M, History of oral contraception, Eur J Contracept Reprod Health Care, 2010;15(2):S12-18","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"3","key":"ref4","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3892\/etm.2015.2203","article-title":"Oral toxicity of isotretinoin, misoprostol, methotrexate, mifepristone and levonorgestrel as pregnancy category X medications in female mice","volume":"9","author":"Kim SK, Shin SJ, Yoo Y, Kim NH, Kim DS, Zhang D","year":"2015","unstructured":"4. Kim SK, Shin SJ, Yoo Y, Kim NH, Kim DS, Zhang D, Oral toxicity of isotretinoin, misoprostol, methotrexate, mifepristone and levonorgestrel as pregnancy category X medications in female mice, Exp Ther Med, 2015;9(3):853-859","journal-title":"Exp Ther Med"},{"issue":"7176","key":"ref5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/bmj.318.7176.96","article-title":"Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners\u2019 oral contraception study","volume":"318","author":"Beral V, Hermon C, Kay C, Hannaford P, Darby S, Reeves G","year":"1999","unstructured":"5. Beral V, Hermon C, Kay C, Hannaford P, Darby S, Reeves G, Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners\u2019 oral contraception study, BMJ, 1999;318(7176):96-100","journal-title":"BMJ"},{"issue":"10","key":"ref6","doi-asserted-by":"publisher","first-page":"821","DOI":"10.7326\/0003-4819-120-10-199405150-00002","article-title":"Oral contraceptive use and mortality during 12 years of follow-up: the Nurses\u2019 Health Study","volume":"120","author":"Colditz GA","year":"1994","unstructured":"6. Colditz GA, Oral contraceptive use and mortality during 12 years of follow-up: the Nurses\u2019 Health Study, Ann Intern Med, 1994;120(10):821-826","journal-title":"Ann Intern Med"},{"issue":"6","key":"ref7","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.contraception.2013.08.008","article-title":"Oral contraceptive use and cancer: final report from the Oxford-Family Planning Association contraceptive study","volume":"88","author":"Vessey M, Yeates D","year":"2013","unstructured":"7. Vessey M, Yeates D, Oral contraceptive use and cancer: final report from the Oxford-Family Planning Association contraceptive study, Contraception, 2013;88(6):678-683","journal-title":"Contraception"},{"issue":"6","key":"ref8","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/humupd\/dmq022","article-title":"Hormonal contraception and risk of cancer","volume":"16","author":"Cibula D, Gompel A, Mueck AO, La Vecchia C, Hannaford PC, Skouby SO","year":"2010","unstructured":"8. Cibula D, Gompel A, Mueck AO, La Vecchia C, Hannaford PC, Skouby SO, Hormonal contraception and risk of cancer, Hum Reprod Update, 2010;16(6):631-650","journal-title":"Hum Reprod Update"},{"issue":"2","key":"ref9","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/annonc\/mdn589","article-title":"Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study","volume":"20","author":"Koomen ER, Joosse A, Herings RM, Casparie MK, Guchelaar HJ, Nijsten T","year":"2009","unstructured":"9. Koomen ER, Joosse A, Herings RM, Casparie MK, Guchelaar HJ, Nijsten T, Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study, Ann Oncol, 2009;20(2):358-364","journal-title":"Ann Oncol"},{"issue":"8","key":"ref10","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1200\/JCO.1987.5.8.1256","article-title":"Estrogen receptor in malignant melanoma","volume":"5","author":"Walker MJ, Beattie CW, Patel MK, Ronan SM, Das Gupta TK","year":"1987","unstructured":"10. Walker MJ, Beattie CW, Patel MK, Ronan SM, Das Gupta TK, Estrogen receptor in malignant melanoma, J Clin Oncol, 1987;5(8):1256-1261","journal-title":"J Clin Oncol"},{"issue":"2","key":"ref11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.4183\/aeb.2016.234","article-title":"The role of estrogens and estrogen receptors in melanoma development and progression","volume":"12","author":"Caruntu C, Mirica A, Ro\u015fca AE, Mirica R, Caruntu A, Tampa M","year":"2016","unstructured":"11. Caruntu C, Mirica A, Ro\u015fca AE, Mirica R, Caruntu A, Tampa M, The role of estrogens and estrogen receptors in melanoma development and progression, Acta Endocrinol (Buchar), 2016;12(2):234-241","journal-title":"Acta Endocrinol (Buchar)"},{"issue":"1","key":"ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5653\/cerm.2012.39.1.1","article-title":"Effect of electromagnetic field exposure on the reproductive system","volume":"39","author":"Gye MC, Park CJ","year":"2012","unstructured":"12. Gye MC, Park CJ, Effect of electromagnetic field exposure on the reproductive system, Clin Exp Reprod Med, 2012;39(1):1-9","journal-title":"Clin Exp Reprod Med"},{"issue":"2","key":"ref13","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/s1734-1140(13)71017-x","article-title":"Changes in antioxidant capacity of blood due to mutual action of electromagnetic field (1800 MHz) and opioid drug (tramadol) in animal model of persistent inflammatory state","volume":"65","author":"Bodera P, Stankiewicz W, Zawada K, Antkowiak B, Paluch M, Kieliszek J","year":"2013","unstructured":"13. Bodera P, Stankiewicz W, Zawada K, Antkowiak B, Paluch M, Kieliszek J, Changes in antioxidant capacity of blood due to mutual action of electromagnetic field (1800 MHz) and opioid drug (tramadol) in animal model of persistent inflammatory state, Pharmacol Rep, 2013;65(2):421-428","journal-title":"Pharmacol Rep"},{"issue":"5","key":"ref14","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s12010-012-0079-9","article-title":"2.45Hz Microwave Irradiation-Induced Oxidative Stress Affects Implantation or Pregnancy in Mice Mus musculus","volume":"169","author":"Shahin S, Singh VP, Shukla RK, Dhawan A, Gangwar RK, Singh SP","year":"2013","unstructured":"14. Shahin S, Singh VP, Shukla RK, Dhawan A, Gangwar RK, Singh SP, 2.45Hz Microwave Irradiation-Induced Oxidative Stress Affects Implantation or Pregnancy in Mice Mus musculus, Appl Biochem Biotechnol, 2013;169(5):1727-1751","journal-title":"Appl Biochem Biotechnol"},{"issue":"5","key":"ref15","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1439-0272.2011.01075.x","article-title":"Impact of cell phone use on men\u2019s semen parameters","volume":"43","author":"Gutschi T, Al-Ali BM, Shamloul R, Pummer K, Trummer H","year":"2011","unstructured":"15. Gutschi T, Al-Ali BM, Shamloul R, Pummer K, Trummer H, Impact of cell phone use on men\u2019s semen parameters, Andrologia, 2011;43(5):312-316","journal-title":"Andrologia"},{"issue":"5","key":"ref16","first-page":"326","article-title":"Effects of various extremely low frequency magnetic fields on the free radical processes, natural antioxidant system and respiratory burst system activates in the heart and liver tissues","volume":"45","author":"Canseven AG, Coskun S, Seyhan N","year":"2008","unstructured":"16. Canseven AG, Coskun S, Seyhan N, Effects of various extremely low frequency magnetic fields on the free radical processes, natural antioxidant system and respiratory burst system activates in the heart and liver tissues, IJBB, 2008;45(5):326-331","journal-title":"IJBB"},{"issue":"5","key":"ref17","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/bem.59","article-title":"Effects ofextremely low frequency magnetic field on fertility of adult male and female rats","volume":"22","author":"Al-Akhras MA, Elbetieha A, Hasan MK, Al-Omari I, Darmani H, Albiss B","year":"2001","unstructured":"17. Al-Akhras MA, Elbetieha A, Hasan MK, Al-Omari I, Darmani H, Albiss B, Effects ofextremely low frequency magnetic field on fertility of adult male and female rats, Bioelectromagnetics, 2001;22(5):340-344","journal-title":"Bioelectromagnetics"},{"issue":"2","key":"ref18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1745-7262.2005.00007.x","article-title":"Evaluation of spermatogenesis and fertility in F1 male rats after in utero and neonatal exposure to extremely low frequency electromagnetic fields","volume":"7","author":"Chung MK, Lee SJ, Kim YB, Park SC, Shin DH, Kim SH","year":"2005","unstructured":"18. Chung MK, Lee SJ, Kim YB, Park SC, Shin DH, Kim SH, Evaluation of spermatogenesis and fertility in F1 male rats after in utero and neonatal exposure to extremely low frequency electromagnetic fields, Asian J Androl, 2005;7(2):189-194","journal-title":"Asian J Androl"},{"issue":"3","key":"ref19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.9775\/kvfd.2010.3410","article-title":"Effects of 900 and 1800MHz Electromagnetic Field Application on Electrocardiogram, Nitric Oxide, Total Antioxidant Capacity, Total Oxidant Capacity, Total Protein, Albumin and Globulin Levels in Guinea Pigs","volume":"17","author":"Cenesiz M, Atakisi O, Akar A, Onbilgin G, Ormanci N","year":"2011","unstructured":"19. Cenesiz M, Atakisi O, Akar A, Onbilgin G, Ormanci N, Effects of 900 and 1800MHz Electromagnetic Field Application on Electrocardiogram, Nitric Oxide, Total Antioxidant Capacity, Total Oxidant Capacity, Total Protein, Albumin and Globulin Levels in Guinea Pigs, Kafkass Univ Vet Fak Derg, 2011;17(3):357-362","journal-title":"Kafkass Univ Vet Fak Derg"},{"issue":"2","key":"ref20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/CM9.0000000000003416","article-title":"Recent global patterns in skin cancer incidence, mortality, and prevalence","volume":"138","author":"Wang M, Gao X, Zhang L","year":"2025","unstructured":"20. Wang M, Gao X, Zhang L, Recent global patterns in skin cancer incidence, mortality, and prevalence, Chin Med J (Engl), 2025;138(2):185-192","journal-title":"Chin Med J (Engl)"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1268479","DOI":"10.3389\/fmed.2023.1268479","article-title":"Advances in melanoma: epidemiology, diagnosis, and prognosis","volume":"10","author":"Waseh S, Lee JB","year":"2023","unstructured":"21. Waseh S, Lee JB, Advances in melanoma: epidemiology, diagnosis, and prognosis, Front Med (Lausanne), 2023;101268479","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"ref22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jaad.2024.09.035","article-title":"Global trends in melanoma burden: A comprehensive analysis from the Global Burden of Disease Study, 1990-2021","volume":"92","author":"Sun Y, Shen Y, Liu Q, Zhang H, Jia L, Chai Y","year":"2025","unstructured":"22. Sun Y, Shen Y, Liu Q, Zhang H, Jia L, Chai Y, Global trends in melanoma burden: A comprehensive analysis from the Global Burden of Disease Study, 1990-2021, J Am Acad Dermatol, 2025;92(1):100-107","journal-title":"J Am Acad Dermatol"},{"issue":"19","key":"ref23","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.3390\/cancers14194652","article-title":"Melanoma Management: From Epidemiology to Treatment and Latest Advances","volume":"14","author":"Lopes J, Rodrigues CMP, Gaspar MM, Reis CP","year":"2022","unstructured":"23. Lopes J, Rodrigues CMP, Gaspar MM, Reis CP, Melanoma Management: From Epidemiology to Treatment and Latest Advances, Cancers (Basel), 2022;14(19):4652","journal-title":"Cancers (Basel)"},{"issue":"6","key":"ref24","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1093\/annonc\/mdm087","article-title":"Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands","volume":"18","author":"de Vries E, Houterman S, Janssen-Heijnen ML, Nijsten T, van de Schans SA, Eggermont AM","year":"2007","unstructured":"24. de Vries E, Houterman S, Janssen-Heijnen ML, Nijsten T, van de Schans SA, Eggermont AM, Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands, Ann Oncol, 2007;18(6):1110-1116","journal-title":"Ann Oncol"},{"issue":"17","key":"ref25","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1016\/j.ejca.2007.09.004","article-title":"Is statin use associated with a reduced incidence, a reduced Breslow thickness or delayed metastasis of melanoma of the skin?","volume":"43","author":"Koomen ER, Joosse A, Herings RM, Casparie MK, Bergman W, Nijsten T","year":"2007","unstructured":"25. Koomen ER, Joosse A, Herings RM, Casparie MK, Bergman W, Nijsten T, Is statin use associated with a reduced incidence, a reduced Breslow thickness or delayed metastasis of melanoma of the skin?, Eur J Cancer, 2007;43(17):2580-2589","journal-title":"Eur J Cancer"},{"issue":"11","key":"ref26","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1097\/00007611-198011000-00023","article-title":"Malignant melanoma associated with breast cancer","volume":"73","author":"Schoenberg BS, Christine BW","year":"1980","unstructured":"26. Schoenberg BS, Christine BW, Malignant melanoma associated with breast cancer, South Med J, 1980;73(11):1493-1497","journal-title":"South Med J"},{"issue":"6","key":"ref27","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/bjc.1977.265","article-title":"Malignant melanoma and oral contraceptive use among women in California","volume":"36","author":"Beral V, Ramcharan S, Faris R","year":"1977","unstructured":"27. Beral V, Ramcharan S, Faris R, Malignant melanoma and oral contraceptive use among women in California, Br J Cancer, 1977;36(6):804-809","journal-title":"Br J Cancer"},{"issue":"6","key":"ref28","first-page":"345","article-title":"The Walnut Creek Contraceptive Drug Study. A prospective study of the side effects of oral contraceptives. Volume III an interim report: A comparison of disease occurrence leading to hospitalization or death in users and nonusers of oral contraceptives","volume":"25","author":"Ramcharan S, Pellegrin FA, Ray RM, Hsu JP","year":"1980","unstructured":"28. Ramcharan S, Pellegrin FA, Ray RM, Hsu JP, The Walnut Creek Contraceptive Drug Study. A prospective study of the side effects of oral contraceptives. Volume III an interim report: A comparison of disease occurrence leading to hospitalization or death in users and nonusers of oral contraceptives, J Reprod Med, 1980;25(6):345-72","journal-title":"J Reprod Med"},{"issue":"5","key":"ref29","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/sj.bjc.6690787","article-title":"Oral contraceptive use and risk of melanoma in premenopausal women","volume":"81","author":"Feskanich D, Hunter DJ, Willett WC, Spiegelman D, Stampfer MJ, Speizer FE","year":"1999","unstructured":"29. Feskanich D, Hunter DJ, Willett WC, Spiegelman D, Stampfer MJ, Speizer FE, Oral contraceptive use and risk of melanoma in premenopausal women, Br J Cancer, 1999;81(5):918-923","journal-title":"Br J Cancer"},{"issue":"6","key":"ref30","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/BF00052752","article-title":"Oral contraceptive use and risk of cutaneous malignant melanoma","volume":"3","author":"Palmer JR, Rosenberg L, Strom BL, Harlap S, Zauber AG, Warshauer ME","year":"1992","unstructured":"30. Palmer JR, Rosenberg L, Strom BL, Harlap S, Zauber AG, Warshauer ME, Oral contraceptive use and risk of cutaneous malignant melanoma, Cancer Causes Control, 1992;3(6):547-554","journal-title":"Cancer Causes Control"},{"issue":"3","key":"ref31","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/bjc.1991.99","article-title":"Oral contraceptives and malignant melanoma","volume":"63","author":"Hannaford PC, Villard-Mackintosh L, Vessey MP, Kay CR","year":"1991","unstructured":"31. Hannaford PC, Villard-Mackintosh L, Vessey MP, Kay CR, Oral contraceptives and malignant melanoma, Br J Cancer, 1991;63(3):430-433","journal-title":"Br J Cancer"},{"issue":"9","key":"ref32","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/bjc.1996.216","article-title":"Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factors","volume":"73","author":"Westerdahl J, Olsson H, M\u00e5sb\u00e4ck A, Ingvar C, Jonsson N","year":"1996","unstructured":"32. Westerdahl J, Olsson H, M\u00e5sb\u00e4ck A, Ingvar C, Jonsson N, Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factors, Br J Cancer, 1996;73(9):1126-1131","journal-title":"Br J Cancer"},{"issue":"10","key":"ref33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/djx144","article-title":"Current gaps in ovarian cancer epidemiology: The need for new population-based research","volume":"109","author":"Doherty JA, Jensen A, Kelemen LE, Pearce CL, Poole E, Schildkraut JM, Terry KL, Tworoger SS, Webb PM, Wentzensen N, Epidemiology Working Group Steering Committee, Ovarian Cancer Association Consortium Members of the EWG SC, in alphabetical order:","year":"2017","unstructured":"33. Doherty JA, Jensen A, Kelemen LE, Pearce CL, Poole E, Schildkraut JM, Terry KL, Tworoger SS, Webb PM, Wentzensen N, Epidemiology Working Group Steering Committee, Ovarian Cancer Association Consortium Members of the EWG SC, in alphabetical order:, Current gaps in ovarian cancer epidemiology: The need for new population-based research, J Natl Cancer Inst, 2017;109(10):1-7","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"ref34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/2042098614548857","article-title":"Combined hormonal contraceptives: Prescribing patterns, compliance, and benefits versus risks","volume":"5","author":"Brynhildsen J","year":"2014","unstructured":"34. Brynhildsen J, Combined hormonal contraceptives: Prescribing patterns, compliance, and benefits versus risks, Ther Adv Drug Saf, 2014;5(5):201-213","journal-title":"Ther Adv Drug Saf"},{"issue":"13","key":"ref35","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1002\/cncr.32846","article-title":"Forty-year trends in menopausal hormone therapy use and breast cancer incidence among postmenopausal black and white women","volume":"126","author":"Chlebowski RT, Aragaki AK, Anderson GL, Prentice RL","year":"2020","unstructured":"35. Chlebowski RT, Aragaki AK, Anderson GL, Prentice RL, Forty-year trends in menopausal hormone therapy use and breast cancer incidence among postmenopausal black and white women, Cancer, 2020;126(13):2956-2964","journal-title":"Cancer"},{"issue":"6","key":"ref36","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/GME.0000000000001282","article-title":"Menopausal hormone therapy trends before versus after 2002","volume":"26","author":"Crawford SL, Crandall CJ, Derby CA, El Khoudary SR, Waetjen LE, Fischer M","year":"2018","unstructured":"36. Crawford SL, Crandall CJ, Derby CA, El Khoudary SR, Waetjen LE, Fischer M, Menopausal hormone therapy trends before versus after 2002, Menopause, 2018;26(6):588-597","journal-title":"Menopause"},{"issue":"5Part B","key":"ref37","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.ijwd.2021.06.005","article-title":"Hormone therapy and melanoma in women","volume":"7","author":"Hill MS, Cartron AM, Burgoyne M, Driscoll MS","year":"2021","unstructured":"37. Hill MS, Cartron AM, Burgoyne M, Driscoll MS, Hormone therapy and melanoma in women, Int J Womens Dermatol, 2021;7(5Part B):692-696","journal-title":"Int J Womens Dermatol"},{"issue":"11","key":"ref38","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.3390\/ijms19113600","article-title":"Ethinylestradiol and Levonorgestrel as Active Agents in Normal Skin, and Pathological Conditions Induced by UVB Exposure: In Vitro and In Ovo Assessments","volume":"19","author":"Coricovac D, Farcas C, Nica C, Pinzaru I, Simu S, Stoian D","year":"2018","unstructured":"38. Coricovac D, Farcas C, Nica C, Pinzaru I, Simu S, Stoian D, Ethinylestradiol and Levonorgestrel as Active Agents in Normal Skin, and Pathological Conditions Induced by UVB Exposure: In Vitro and In Ovo Assessments, International Journal of Molecular Sciences, 2018;19(11):3600","journal-title":"International Journal of Molecular Sciences"},{"issue":"12","key":"ref39","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1038\/jid.2009.168","article-title":"Oral contraceptives: a risk factor for squamous cell carcinoma?","volume":"129","author":"Applebaum KM, Nelson HH, Zens MS, Stukel TA, Spencer SK, Karagas MR","year":"2009","unstructured":"39. Applebaum KM, Nelson HH, Zens MS, Stukel TA, Spencer SK, Karagas MR, Oral contraceptives: a risk factor for squamous cell carcinoma?, J Invest Dermatol, 2009;129(12):2760-2765","journal-title":"J Invest Dermatol"},{"issue":"5","key":"ref40","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.31925\/farmacia.2024.5.16","article-title":"In vitro assessment of 17\u00df-ethinylestradiol and levonorgestrel on breast cancer MCF-7 and MDA-MB 231 cell lines","volume":"72","author":"Borozan F, Sas I, Blidisel A, Haj Ali D, Pasc A, Dumitrescu C","year":"2024","unstructured":"40. Borozan F, Sas I, Blidisel A, Haj Ali D, Pasc A, Dumitrescu C, In vitro assessment of 17\u00df-ethinylestradiol and levonorgestrel on breast cancer MCF-7 and MDA-MB 231 cell lines, FARMACIA, 2024;72(5):1131-1141","journal-title":"FARMACIA"},{"issue":"4","key":"ref41","doi-asserted-by":"publisher","first-page":"477","DOI":"10.15386\/mpr-2747","article-title":"Retrospective study of the factors involved in the development of adenomyosis and the in vitro link between adenomyosis and breast cancer","volume":"97","author":"Borozan F, Semenescu AD, Sas I, Bernad E, Iftode A, Iftode C","year":"2024","unstructured":"41. Borozan F, Semenescu AD, Sas I, Bernad E, Iftode A, Iftode C, Retrospective study of the factors involved in the development of adenomyosis and the in vitro link between adenomyosis and breast cancer, Med Pharm Rep, 2024;97(4):477-487","journal-title":"Med Pharm Rep"},{"issue":"9","key":"ref42","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.3390\/molecules26092776","article-title":"Insights into the Behavior of Triple-Negative MDA-MB-231 Breast Carcinoma Cells Following the Treatment with 17\u03b2-Ethinylestradiol and Levonorgestrel","volume":"26","author":"Simu S, Marcovici I, Dobrescu A, Malita D, Dehelean CA, Coricovac D","year":"2021","unstructured":"42. Simu S, Marcovici I, Dobrescu A, Malita D, Dehelean CA, Coricovac D, Insights into the Behavior of Triple-Negative MDA-MB-231 Breast Carcinoma Cells Following the Treatment with 17\u03b2-Ethinylestradiol and Levonorgestrel, Molecules, 2021;26(9):2776","journal-title":"Molecules"},{"issue":"7","key":"ref43","doi-asserted-by":"publisher","first-page":"e3008","DOI":"10.1210\/clinem\/dgac150","article-title":"Estradiol Valerate vs Ethinylestradiol in Combined Oral Contraceptives: Effects on the Pituitary-Ovarian Axis","volume":"107","author":"Haverinen A, Luiro K, Kangasniemi MH, Piltonen TT, Hustad S, Heikinheimo O","year":"2022","unstructured":"43. Haverinen A, Luiro K, Kangasniemi MH, Piltonen TT, Hustad S, Heikinheimo O, Estradiol Valerate vs Ethinylestradiol in Combined Oral Contraceptives: Effects on the Pituitary-Ovarian Axis, J Clin Endocrinol Metab, 2022;107(7):e3008-e3017","journal-title":"J Clin Endocrinol Metab"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.contraception.2022.08.009","article-title":"Effects of estradiol-and ethinylestradiol-based contraceptives on adrenal steroids: A randomized trial","volume":"116","author":"Kangasniemi MH, Arffman RK, Haverinen A, Luiro K, Hustad S, Heikinheimo O","year":"2022","unstructured":"44. Kangasniemi MH, Arffman RK, Haverinen A, Luiro K, Hustad S, Heikinheimo O, Effects of estradiol-and ethinylestradiol-based contraceptives on adrenal steroids: A randomized trial, Contraception, 2022;11659-65","journal-title":"Contraception"},{"issue":"13","key":"ref45","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1111\/1471-0528.17268","article-title":"Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case-control analysis using German claims data","volume":"129","author":"Schink T, Princk C, Braitmaier M, Haug U","year":"2022","unstructured":"45. Schink T, Princk C, Braitmaier M, Haug U, Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case-control analysis using German claims data, BJOG, 2022;129(13):2107-2116","journal-title":"BJOG"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/all-issues\/2025\/issue-8-2025\/original-article-issue-8-2025\/recent-investigations-on-the-impact-of-levonorgestrel-and-17%ce%b2-ethinylestradiol-on-melanoma\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T14:04:36Z","timestamp":1763388276000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/all-issues\/2025\/issue-8-2025\/original-article-issue-8-2025\/recent-investigations-on-the-impact-of-levonorgestrel-and-17%ce%b2-ethinylestradiol-on-melanoma\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["JMedLife-18-804"],"URL":"https:\/\/doi.org\/10.25122\/jml-2025-0125","relation":{},"ISSN":["1844-3117"],"issn-type":[{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]}}}